f-EBM Therapy

About Helios Cardio

Helios Cardio is a private, clinical-stage biotech targeting major unmet needs in cardiovascular disease through a regenerative medicine platform. Its lead product, CardiaMend™, is an FDA-cleared device for pericardial and epicardial repair, providing an initial commercial foothold. The company's broader pipeline leverages its proprietary f-EBM scaffold, investigating it both as a monotherapy and in combination with cells or drugs for indications like heart failure and postoperative complications, led by a team with a proven track record in regenerative medicine.

Therapeutic Areas

Other Postoperative Atrial Fibrillation Drugs